154 related articles for article (PubMed ID: 36529658)
1. Validation of the kidney failure risk equation in a Portuguese cohort.
da Silva BM; Charreu J; Duarte I; Outerelo C; Gameiro J
Nefrologia (Engl Ed); 2023; 43(4):467-473. PubMed ID: 36529658
[TBL] [Abstract][Full Text] [Related]
2. Utility of the Kidney Failure Risk Equation and Estimated GFR for Estimating Time to Kidney Failure in Advanced CKD.
Chu CD; McCulloch CE; Hsu RK; Powe NR; Bieber B; Robinson BM; Raina R; Pecoits-Filho R; Tuot DS
Am J Kidney Dis; 2023 Oct; 82(4):386-394.e1. PubMed ID: 37301501
[TBL] [Abstract][Full Text] [Related]
3. Planning vascular access creation: The promising role of the kidney failure risk equation.
Marques da Silva B; Dores M; Silva O; Pereira M; Outerelo C; Fortes A; Lopes JA; Gameiro J
J Vasc Access; 2023 Jul; ():11297298231186373. PubMed ID: 37475542
[TBL] [Abstract][Full Text] [Related]
4. The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study.
Major RW; Shepherd D; Medcalf JF; Xu G; Gray LJ; Brunskill NJ
PLoS Med; 2019 Nov; 16(11):e1002955. PubMed ID: 31693662
[TBL] [Abstract][Full Text] [Related]
5. Independent External Validation and Comparison of Death and Kidney Replacement Therapy Prediction Models in Advanced CKD.
Thanabalasingam SJ; Iliescu EA; Norman PA; Day AG; Akbari A; Hundemer GL; White CA
Kidney Med; 2022 Apr; 4(4):100440. PubMed ID: 35445190
[TBL] [Abstract][Full Text] [Related]
6. Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia.
Wang Y; Nguyen FNHL; Allen JC; Lew JQL; Tan NC; Jafar TH
BMC Nephrol; 2019 Dec; 20(1):451. PubMed ID: 31801468
[TBL] [Abstract][Full Text] [Related]
7. A validation study of the kidney failure risk equation in advanced chronic kidney disease according to disease aetiology with evaluation of discrimination, calibration and clinical utility.
Ali I; Donne RL; Kalra PA
BMC Nephrol; 2021 May; 22(1):194. PubMed ID: 34030639
[TBL] [Abstract][Full Text] [Related]
8. Use of the Kidney Failure Risk Equation to Determine the Risk of Progression to End-stage Renal Disease in Children With Chronic Kidney Disease.
Winnicki E; McCulloch CE; Mitsnefes MM; Furth SL; Warady BA; Ku E
JAMA Pediatr; 2018 Feb; 172(2):174-180. PubMed ID: 29255845
[TBL] [Abstract][Full Text] [Related]
9. Validation of the kidney failure risk equation in European CKD patients.
Peeters MJ; van Zuilen AD; van den Brand JA; Bots ML; Blankestijn PJ; Wetzels JF;
Nephrol Dial Transplant; 2013 Jul; 28(7):1773-9. PubMed ID: 23645476
[TBL] [Abstract][Full Text] [Related]
10. Validation of the kidney failure risk equation in predicting the risk of progression to kidney failure in a multi-ethnic Singapore chronic kidney disease cohort.
Kwek JL; Pang HQJ; Li H; Lim WWL; Choo JCJ; Choong HL; Foo MWY; Chan CM
Singapore Med J; 2022 Jun; 63(6):313-318. PubMed ID: 36043308
[TBL] [Abstract][Full Text] [Related]
11. Validation of the Kidney Failure Risk Equation in Manitoba.
Whitlock RH; Chartier M; Komenda P; Hingwala J; Rigatto C; Walld R; Dart A; Tangri N
Can J Kidney Health Dis; 2017; 4():2054358117705372. PubMed ID: 28491341
[TBL] [Abstract][Full Text] [Related]
12. Using the kidney failure risk equation to predict end-stage kidney disease in CKD patients of South Asian ethnicity: an external validation study.
Maher F; Teece L; Major RW; Bradbury N; Medcalf JF; Brunskill NJ; Booth S; Gray LJ
Diagn Progn Res; 2023 Oct; 7(1):22. PubMed ID: 37798742
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of the Kidney Failure Risk Equation for vascular access planning.
Lundström UH; Ramspek CL; Dekker FW; van Diepen M; Carrero JJ; Hedin U; Evans M
Nephrol Dial Transplant; 2024 Mar; ():. PubMed ID: 38486367
[TBL] [Abstract][Full Text] [Related]
14. Prediction of End-Stage Kidney Disease Using Estimated Glomerular Filtration Rate With and Without Race : A Prospective Cohort Study.
Bundy JD; Mills KT; Anderson AH; Yang W; Chen J; He J;
Ann Intern Med; 2022 Mar; 175(3):305-313. PubMed ID: 35007146
[TBL] [Abstract][Full Text] [Related]
15. Serum Potassium and Risk of Death or Kidney Replacement Therapy in Older People With CKD Stages 4-5: Eight-Year Follow-up.
de Rooij ENM; de Fijter JW; Le Cessie S; Hoorn EJ; Jager KJ; Chesnaye NC; Evans M; Windahl K; Caskey FJ; Torino C; Szymczak M; Drechsler C; Wanner C; Dekker FW; Hoogeveen EK;
Am J Kidney Dis; 2023 Sep; 82(3):257-266.e1. PubMed ID: 37182596
[TBL] [Abstract][Full Text] [Related]
16. The kidney failure risk equation predicts kidney failure: Validation in an Australian cohort.
Irish GL; Cuthbertson L; Kitsos A; Saunder T; Clayton PA; Jose MD
Nephrology (Carlton); 2023 Jun; 28(6):328-335. PubMed ID: 37076122
[TBL] [Abstract][Full Text] [Related]
17. Death and Dialysis Following Discharge From Chronic Kidney Disease Clinic: A Retrospective Cohort Study.
Che M; Iliescu E; Thanabalasingam S; Day AG; White CA
Can J Kidney Health Dis; 2022; 9():20543581221118434. PubMed ID: 35992302
[TBL] [Abstract][Full Text] [Related]
18. Validation of the Kidney Failure Risk Equation in Kidney Transplant Recipients.
Tangri N; Ferguson TW; Wiebe C; Eng F; Nash M; Astor BC; Lam NN; Ye F; Shin JI; Whitlock R; Yuen DA
Can J Kidney Health Dis; 2020; 7():2054358120922627. PubMed ID: 32549052
[TBL] [Abstract][Full Text] [Related]
19. Comparison of a Kidney Replacement Therapy Risk Score Developed in Kaiser Permanente Northwest vs Estimated Glomerular Filtration Rate in Advanced Chronic Kidney Disease Using Decision Curve Analysis.
Park KJ; Benuzillo JG; Keast E; Thorp ML; Mosen DM; Johnson ES
Perm J; 2021 Dec; 25():. PubMed ID: 35348109
[TBL] [Abstract][Full Text] [Related]
20. Potential impact of NICE guidelines on referrals from primary care to nephrology: a primary care database and prospective research study.
Sullivan MK; Jani BD; Rutherford E; Welsh P; McConnachie A; Major RW; McAllister D; Nitsch D; Mair FS; Mark PB; Lees JS
Br J Gen Pract; 2023 Feb; 73(727):e141-e147. PubMed ID: 36376072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
